Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention

Published:2022-06 Issue:6 Volume:38 Page:792-800
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Pivato Carlo Andrea,Jones Davis,Cao Davide,Sartori Samantha,Chiarito Mauro,Nicolas Johny,Zhang Zhongjie,Beerkens Frans,Nardin Matteo,Qiu Hanbo,Razuk Victor,Feldman Daniel,Kumaraguru Vaishali,Stefanini Giulio G.,Sweeny Joseph,Baber Usman,Dangas George,Sharma Samin K.,Kini Annapoorna,Mehran Roxana^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Cardiovascular risk in diabetes: a brief review;Marks;J Diabetes Complications,2000

2. Do atherosclerosis and type 2 diabetes share a common inflammatory basis?;Pradhan;Eur Heart J,2002

3. Association between low-grade systemic inflammation and type 2 diabetes mellitus among men and women from the ATTICA STUDY;Pitsavos;Rev Diabet Stud,2007

4. C-Reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus;Pradhan;JAMA,2001

5. Increased levels of C-reactive protein in noncontrolled type II diabetic subjects;Rodríguez-Morán;J Diabetes Complications,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention;Journal of Cardiology;2023-09

2. Lipoxin A4 prevents high glucose-induced inflammatory response in cardiac fibroblast through FOXO1 inhibition;Cellular Signalling;2023-06